4-phenylbutyric acid has been researched along with rifampin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Morris, A; Shneider, BL; Vockley, J | 1 |
Chen, L; Shen, Y; Xu, J; Zhang, W | 1 |
Chen, J; Chen, L; Tang, X; Wu, H | 1 |
1 review(s) available for 4-phenylbutyric acid and rifampin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for 4-phenylbutyric acid and rifampin
Article | Year |
---|---|
Possible Phenylacetate Hepatotoxicity During 4-Phenylbutyrate Therapy of Byler Disease.
Topics: Antineoplastic Agents; Bilirubin; Chemical and Drug Induced Liver Injury; Child, Preschool; Cholestasis, Intrahepatic; Humans; Infant; Liver; Liver Function Tests; Male; Phenylacetates; Phenylbutyrates; Pruritus; Rifampin | 2016 |
Rifampicin-induced injury in L02 cells is alleviated by 4-PBA via inhibition of the PERK-ATF4-CHOP pathway.
Topics: Activating Transcription Factor 4; Antibiotics, Antitubercular; Apoptosis; Cell Line; Cell Survival; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Phenylbutyrates; Protective Agents; Rifampin; Signal Transduction; Transcription Factor CHOP | 2016 |
4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury, Chronic; Cytoprotection; Endoplasmic Reticulum Stress; Hep G2 Cells; Hepatocytes; Humans; Liver; Male; Mice; Mice, Inbred ICR; Multidrug Resistance-Associated Protein 2; Phenylbutyrates; Protective Agents; Rifampin; Signal Transduction; Ubiquitination | 2022 |